B
12.27
-0.64 (-4.96%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | Beta Bionics, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
-0.6
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.63 |
|
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 6.51% |
| 机构持股比例 | 98.41% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 25.00 (Truist Securities, 103.75%) | 购买 |
| 中 | 22.00 (79.30%) | |
| 低 | 14.00 (Baird, 14.10%) | 保留 |
| 平均值 | 20.33 (65.69%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 13.64 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Baird | 18 Feb 2026 | 14.00 (14.10%) | 保留 | 13.61 |
| Stifel | 18 Feb 2026 | 22.00 (79.30%) | 购买 | 13.61 |
| 04 Feb 2026 | 25.00 (103.75%) | 购买 | 14.09 | |
| Truist Securities | 02 Feb 2026 | 25.00 (103.75%) | 购买 | 13.70 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合